According to Ocugen's latest financial reports the company has $39.46 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $90.93 M | -4.24% |
2021-12-31 | $94.95 M | 295.02% |
2020-12-31 | $24.03 M | 222.93% |
2019-12-31 | $7.44 M | -52.1% |
2018-12-31 | $15.54 M | 94.74% |
2017-12-31 | $7.98 M | -74.99% |
2016-12-31 | $31.9 M | 3.21% |
2015-12-31 | $30.91 M | -47.18% |
2014-12-31 | $58.52 M | 570.11% |
2013-12-31 | $8.73 M | -40.65% |
2012-12-31 | $14.71 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 427.56% | ๐บ๐ธ USA |